Lisa Evoli's Insider Trades & SAST Disclosures
Lisa Evoli's most recent trade in Catalent Inc. was a trade of 3,859 Common Stock done at an average price of $59.7 . Disclosure was reported to the exchange on Aug. 2, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lisa Evoli.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalent Inc. | Lisa Evoli | SVP, Chief HR Officer | Sale of securities on an exchange or to another person at price $ 59.67 per share. | 02 Aug 2024 | 3,859 | 39,366 (0%) | 0% | 59.7 | 230,267 | Common Stock |
| Catalent Inc. | Lisa Evoli | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 15,338 | 43,225 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 6,201 | 6,201 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 2,532 | 21,137 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 659 | 18,746 (0%) | 0% | 52.6 | 34,670 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 483 | 20,654 (0%) | 0% | 52.9 | 25,536 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 448 | 19,929 (0%) | 0% | 52.9 | 23,686 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 300 | 18,446 (0%) | 0% | 52.6 | 15,783 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 277 | 20,377 (0%) | 0% | 52.9 | 14,645 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 269 | 19,660 (0%) | 0% | 52.9 | 14,222 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 255 | 19,405 (0%) | 0% | 52.9 | 13,482 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 27 Feb 2023 | 3,767 | 18,605 (0%) | 0% | 57.0 | 214,731 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,552 | 19,549 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,137 | 22,372 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,054 | 21,235 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 632 | 20,181 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.81 per share. | 10 Aug 2022 | 1,165 | 17,997 (0%) | 0% | 55.8 | 65,020 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.34 per share. | 03 Aug 2022 | 293 | 19,162 (0%) | 0% | 55.3 | 16,215 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.87 per share. | 01 Aug 2022 | 456 | 19,455 (0%) | 0% | 56.9 | 25,933 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.93 per share. | 15 Jun 2022 | 900 | 19,911 (0%) | 0% | 55.9 | 50,337 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 59.85 per share. | 24 May 2022 | 250 | 20,811 (0%) | 0% | 59.9 | 14,963 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 7,680 | 23,713 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 5,553 | 5,553 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 1,975 | 16,033 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 704 | 21,061 (0%) | 0% | 65.1 | 45,837 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 657 | 22,498 (0%) | 0% | 65.1 | 42,777 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 430 | 21,765 (0%) | 0% | 65.1 | 27,997 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 394 | 23,155 (0%) | 0% | 65.1 | 25,653 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 188 | 22,310 (0%) | 0% | 65.1 | 12,241 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 164 | 23,549 (0%) | 0% | 65.1 | 10,678 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 115 | 22,195 (0%) | 0% | 65.1 | 7,488 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 67.03 per share. | 28 Feb 2022 | 1,254 | 14,058 (0%) | 0% | 67.0 | 84,056 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,830 | 15,312 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,566 | 11,482 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,566 | 8,916 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.39 per share. | 01 Aug 2021 | 286 | 7,539 (0%) | 0% | 72.4 | 20,704 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.62 per share. | 01 Aug 2021 | 189 | 7,350 (0%) | 0% | 70.6 | 13,347 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 10 May 2021 | 2,745 | 7,825 (0%) | 0% | 75 | 205,875 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.91 per share. | 10 May 2021 | 2,745 | 10,570 (0%) | 0% | 55.9 | 153,473 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 2,745 | 2,746 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.39 per share. | 10 May 2021 | 2,590 | 10,415 (0%) | 0% | 43.4 | 112,380 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 10 May 2021 | 2,590 | 7,825 (0%) | 0% | 75 | 194,250 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 2,590 | 7,771 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.23 per share. | 14 Apr 2021 | 3,440 | 11,265 (0%) | 0% | 56.2 | 193,431 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 3,440 | 1,147 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 3,440 | 7,825 (0%) | 0% | 70 | 240,800 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2021 | 1,785 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 1,785 | 7,825 (0%) | 0% | 70 | 124,950 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.68 per share. | 14 Apr 2021 | 1,785 | 9,610 (0%) | 0% | 43.7 | 77,969 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 14 Apr 2021 | 1,081 | 7,825 (0%) | 0% | 70 | 75,670 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 5,472 | 5,472 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 1,815 | 9,317 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 188 | 9,017 (0%) | 0% | 68.1 | 12,803 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 112 | 9,205 (0%) | 0% | 68.1 | 7,627 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 111 | 8,906 (0%) | 0% | 68.1 | 7,559 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 4,424 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 09 Nov 2020 | 4,424 | 7,502 (0%) | 0% | 51 | 225,624 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.58 per share. | 09 Nov 2020 | 4,424 | 11,926 (0%) | 0% | 32.6 | 144,156 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 2,552 | 1,785 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 55.18 per share. | 09 Nov 2020 | 2,552 | 7,502 (0%) | 0% | 55.2 | 140,824 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.68 per share. | 09 Nov 2020 | 2,552 | 10,054 (0%) | 0% | 43.7 | 111,471 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Executive Vice President &CHRO | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 09 Nov 2020 | 754 | 7,502 (0%) | 0% | 51 | 38,454 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 2,087 | 8,256 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Lisa Evoli | EVP & Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.75 per share. | 01 Aug 2020 | 286 | 6,169 (0%) | 0% | 47.8 | 13,657 | Common Stock |
| Integra Lifesciences Holdi... | Lisa Evoli | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 05 Jun 2020 | 3,475 | 6,455 (0%) | 0% | 55 | 191,125 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges